Scientific Letters
Vol. 18 No. 1 (2026): Mediterranean Journal of Hematology and Infectious Diseases
CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: April 30, 2026
0
Views
0
Downloads
0
HTML
Authors
The CD56briCD38+ neutrophil subset in peripheral blood (PB) exceeding 2.0% may represent as a highly specific and rapid flow cytometric signature for the early detection of Chronic Myeloid Leukemia (CML).
Downloads
Download data is not yet available.
Citations
1. Khoury JD, Solary E, Abla O, et al. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms. Leukemia. 2022;36(7):1703-1719. doi:10.1038/s41375-022-01613-1
2. Jabbour E, Kantarjian H. Chronic myeloid leukemia: 2025 update on diagnosis, therapy, and monitoring. Am J Hematol. 2024;99(11):2191-2212. doi:10.1002/ajh.27443
3. Lanza F, Bi S, Castoldi G, Goldman JM. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia. Leukemia. 1993;7(10):1570-1575.
4. Raspadori D, Pacelli P, Sicuranza A, et al. Flow Cytometry Assessment of CD26+ Leukemic Stem Cells in Peripheral Blood: A Simple and Rapid New Diagnostic Tool for Chronic Myeloid Leukemia. Cytometry B Clin Cytom. 2019;96(4):294-299. doi:10.1002/cyto.b.21764
5. Sharma P, Sachdeva MUS, Naseem S, et al. Identification of peripheral blood CD26+ leukemic stem cells has a potential role in the rapid diagnosis of chronic myeloid leukemia. Int J Lab Hematol. 2022;44(3):518-523. doi:10.1111/ijlh.13807
6. Huang P, Zhang C, Zhang A, et al. CD56briCD38+ as a novel neutrophil-specific marker in chronic myeloid leukemia. Heliyon. 2024;10(21):e39465. doi:10.1016/j.heliyon.2024.e39465
7. Wood B. Multicolor immunophenotyping: human immune system hematopoiesis. Methods Cell Biol. 2004;75:559-576. doi:10.1016/s0091-679x(04)75023-2
8. Van Dongen JJ, Macintyre EA, Gabert JA, et al. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia. Leukemia. 1999;13(12):1901-1928. doi:10.1038/sj.leu.2401592
9. Cottini F, Rodriguez J, Hughes T, et al. Redefining CD56 as a Biomarker and Therapeutic Target in Multiple Myeloma. Mol Cancer Res. 2022;20(7):1083-1095. doi:10.1158/1541-7786.MCR-21-0828
Ethics Approval
Chronic Myeloid Leukemia (CML), Multiparameter flow cytometry (MFC)How to Cite
“CD56+/CD38+ Neutrophils: Rapid and Specific Flow Cytometric Signature for Chronic Myeloid Leukemia” (2026) Mediterranean Journal of Hematology and Infectious Diseases, 18(1). doi:10.4084/MJHID.2026.049.
Copyright (c) 2026 Alessandro Laganà, Matteo Breccia, Loredana Elia, Emilia Scalzulli, Maria Laura Bisegna, Claudia Ielo, Sonia Buffolino, Attilio Di Lascio, Concetta Anna Germano, Stefania Intoppa, Maria Laura Milani, Maurizio Martelli, Massimo Breccia, Maria Stefania De Propris
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
